capture
[용어속성] Compound
The impact of global and local Polynesian genetic ancestry on complex traits in Native Hawaiians
하와이 원주민의 복잡한 형질에 대한 전 세계 및 지역 폴리네시아 유전 조상의 영향
Research Article
[키워드] adjust
Affect
association
binary trait
Biomarkers
BMI
Cancer
cancers
capture
captures
cardiometabolic
cardiometabolic traits
cardiovascular disease
cardiovascular diseases
chromosomal
chromosome
Cohort
Community
complex
covariate
Culture
diabete
diabetes
Diabetic
disease
disease risk
disparity
driven by
epidemiological studies
European
evaluated
Factor
Genetic
genetic factors
genetic information
genetic risk factor
genetic risk factors
genetic susceptibility
genomic
Hawaiian Islands
Health
heart failure
identify
increase in
increased risk
independent
individual
individuals
Local
mechanism
Native
obesity
Perspective
populations
prevalent
proportion
Quantitative
Questionnaires
reducing
replicate
Replication
risk
risk factor
Risk factors
Samoa
small sample size
SNP
T2D
tested
type-2 diabetes
variant
while
[DOI] 10.1371/journal.pgen.1009273 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pgen.1009273 PMC 바로가기 [Article Type] Research Article
Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase–Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students
무증상 대학생에서 역전사효소-정량적 중합효소 연쇄 반응 또는 CRISPR 기반 분석을 사용한 중증 급성 호흡기 증후군 코로나바이러스 2 선별 검사의 비교
Comparative Study
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
age
approach
assays
Asymptomatic
Asymptomatic case
capture
chain
Chain Reaction
clinical
clinical laboratory
clinical samples
Cohort
cohort study
collected
college
Community
Concordance
Containment
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease 2019
covert
COVID-19
CREST
CRISPR
determine
diagnostic
diagnostic testing
effective
evaluated
exposure
female
finding
highlighting
Importance
improvement
in viral
individual
information
Laboratory
leading edge
Local
lockdown
measure
Measures
Metrics
Mitigation
objective
offer
oropharyngeal swab
outbreak
Outbreaks
pandemic
participant
Point
polymerase chain
polymerase chain reaction
positive
positive result
positive sample
Prevalence
public health
qPCR
reaction
Relaxation
Relevance
reopening
required
respiratory
Result
reverse transcriptase
rising
RT-qPCR
SARS-CoV-2
SARS-CoV-2 testing
screened
Screening
setting
severe acute respiratory syndrome Coronavirus
shift
student
study participant
Study participants
surveillance testing
test results
Testing
universities
Viral
Viral load
viral loads
Viral transmission
virus
virus detection
[DOI] 10.1001/jamanetworkopen.2020.37129 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1001/jamanetworkopen.2020.37129 PMC 바로가기 [Article Type] Comparative Study
Obesity and clinical severity in patients with COVID-19: a scoping review protocol
COVID-19 환자의 비만 및 임상 중증도: 범위 검토 프로토콜
Review
[키워드] (respiratory rate
Abstract
Acute respiratory failure
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
affected
article
articles
breath
capture
caused
China
Clinical outcome
clinical outcomes
Clinical severity
Comorbidities
complications
conflict
coronavirus
coronavirus disease
Course
COVID-19
diagnosed with COVID-19
Diagnosis
disease
Early detection
English
Evidence
fraction
Health Sciences
Hypoxemia
identify
implication
individual
Invasive mechanical ventilation
involved
item
Latin
library
literature
lung
lung field
minute
Mortality
obese
obese patient
obese patients
obesity
Older
open
optimization
outcome
oxygen
oxygen saturation
partial pressure
Patient
patients with obesity
protocol
recommendation
reported
Reporting
Research
resolved
respiratory
Respiratory failure
respiratory rate
review
risk factor
Science
selected
Selection
Selection bias
Severe acute respiratory syndrome
severity
Spanish
supplementary material
systematic reviews
tachypnea
therapy
Treatment
virus
Web of Science
with COVID-19
[DOI] 10.1186/s13643-021-01603-x PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s13643-021-01603-x PMC 바로가기 [Article Type] Review
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
COVID19에 감염된 종양-혈액학적 환자에서 호흡 부전 진행을 예방하기 위한 바리시티닙의 효능을 평가하기 위한 I/II상 임상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
AAK1
absence
activator
Acute respiratory failure
Administered
administration
Adverse
adverse events
affected
alkaline phosphatase
All participants
allergy
Alpha
alpha error
angina pectoris
Antibiotics
appearance
ARDS
Arm
assigned
AST/ALT
Baricitinib
baseline
beta error
Bilirubin
Blinding
Blood
Breastfeeding
can be used
candidate
Candidates
capture
Cardiac arrhythmia
carried
change
clearance
clinical
clinical condition
clinical suspicion
clinical trials
Coagulation
Cohort
Common Terminology Criteria
Comorbidity
Complete
completion
Compliance
congestive heart failure
control arm
Controlled trial
corticoid
Corticosteroids
COVID19
creatinine
creatinine clearance
CRP
D-dimer
Day
Deep venous thrombosis
description
Deterioration
Dexamethasone
dimer
discharge
discretion
disease
dissemination
diverticulitis
dose
dropout rate
Duration of therapy
ECMO
Efficacy
electronic case report form
element
eligibility criteria
Enrollment
evaluate
exclusion criteria
expected
experimental arm
extracorporeal membrane oxygenation
febrile neutropenia
ferritin
followed by
form
fraction
Gas exchange
greater
HBV
HCV
hemodynamic instability
High-flow nasal cannula
HIV
HIV infection
ICU
immobilization
immunological
impossibility
incidence
include
indication
Infection
infection with SARS-CoV-2
Inflammatory response
interfere
interferon
Interim
interim analysis
interleukin
interleukin 6
interstitial pneumonia
Intervention
intestinal perforation
Invasive mechanical ventilation
investigational agent
investigator
jak inhibitors
Jak-STAT
Laboratory
laboratory parameter
Laboratory parameters
LDH
less
limit
limits
management
mechanical ventilation
medical history
Medicine
meet
Methylprednisolone
Mild ARDS
Mortality
multi organ failure
nasal
nasal cannula
need for oxygen
neutropenia
neutrophil
Neutrophils
Non-invasive
number
objective
on mechanical ventilation
oncological patients
onset of symptom
open
open label
oral medication
organ dysfunction
Organ failure
outcome
oxygen
oxygen support
PaFi
participant
Participants
Participation
pathogen
Pathogens
pathway
Patient
patients
performance status
performed
phase
Phase 1
Phase 2
Phase I
phosphatase
platform
Pneumonia
poor prognosis
positive
Prednisone
pregnancy test
pregnant
prejudice
Prevent
progression
Prophylaxis
Protein
protein kinase
protocol
Psychiatric
psychiatric illness
Pulmonary embolism
radiological
randomisation
randomised
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receptor
recruitment
REDCap
REDcap platform
reduce
reduced
Remdesivir
removal
report
reported
required
respiratory
Respiratory failure
Respiratory function
respiratory insufficiency
respiratory tract
Sample size
SARS-CoV-2
SARS-CoV2
SARS-CoV2 infection
Secondary objectives
Sepsis
severe adverse event
severe adverse events
severe pneumonia
severe respiratory failure
Spain
Spanish
Standard of care
STAT
status
study enrollment
Study protocol
supplemental oxygen requirement
supplemental oxygen requirements
supplementary material
Support
surgical
surgical intervention
Symptom
symptomatic
Tablet
Therapies
therapy
thromboembolic disease
thrombosis
Tocilizumab
total bilirubin
Toxicity
Transcription
transducer
Treatment
treatment period
Trial
unstable angina
use of corticosteroid
Venous thrombosis
Version
viral endocytosis
website
Withdrawal
worsening
[DOI] 10.1186/s13063-021-05072-4 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05072-4 PMC 바로가기 [Article Type] Letter
Estimating the time-varying reproduction number of COVID-19 with a state-space method
상태 공간 방법으로 COVID-19의 시변 재생산 수 추정
Research Article
[키워드] adopted
automatically
average
can be used
capture
caused
change
confirmed cases
consequence
country
COVID-19
COVID-19 infections
Critical
dataset
decrease
defined
dependent on
despair
detect
disease
distribution
Effect
event
Hope
Incubation period
Infection
information
mathematical
mathematical model
measure
Measures
media
MONITOR
Novel coronavirus
predict
Reproduction number
risk of infection
Society
Spread
structures
the times
Transmission
variant
[DOI] 10.1371/journal.pcbi.1008679 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pcbi.1008679 PMC 바로가기 [Article Type] Research Article
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
혈액 전사체의 질병 중증도별 호중구 서명은 COVID-19 환자를 계층화합니다
Research
[키워드] acute respiratory distress
acute respiratory distress syndrome
analyzed
Asymptomatic
available data
blood cell
blood transcriptome
Blood transcriptomics
capture
Cell
changes in
clinical
Clinical parameters
Clinical presentations
Co-expression analysis
Cohort
Combination
control sample
COVID-19
COVID-19 patient
data-driven
death
disease severity
dissect
Donor
driver
drug candidate
drug candidates targeting
Drug repurposing
drug target
dysregulated
explained
granulocyte
granulocyte sample
Granulocytes
groups
Host
host responses
identify
immune
immune system
independent
Infection
Inflammatory diseases
Mild
mild respiratory
mild respiratory tract infection
Molecular disease phenotypes
molecular phenotype
molecular subgroup
neutrophil
neutrophil activation
Neutrophil activation-associated signature
Neutrophils
other diseases
parameters
Patient
performed
phenotype
Phenotypes
predicted
provide
report
respiratory
respiratory distress
Respiratory failure
respiratory tract infection
Result
RNA-Seq
SARS-CoV-2 pandemic
Severe case
severe cases
severe COVID-19 patient
Severe patient
Stratification
stratified
supplementary material
syndrome
systemic immune response
Transcriptome
transcriptomes
Viral
viral infections
was used
Whole blood
whole blood transcriptome
PMC 바로가기 [Article Type] Research
PMC 바로가기 [Article Type] Research
Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial
일차 진료 환경(LIBERTY)에서 Covid-19 감염 성인 환자 치료에 사용되는 하이드록시클로로퀸: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
addition
addressed
administration
Adult patients
adverse event
adverse events
AEs
age
all-cause hospitalization
Antibody Response
Anxiety
Anxiety Disorder
ARMS
association
Biomarker
blinded
Blinding
Blood
BMI
capture
Care
changes
changes in
Characteristics
clinical trial
concentrations
concomitant medications
conducted
Contact
Course
COVID-19
COVID-19 infection
COVID-19-related symptoms
criteria
death
deleting
Demographic variables
diabetes
Diabetes Mellitus
disease
dissemination
double-blind
Effect
element
enrolment
enzyme
EudraCT
evaluate
exclusion
expected
exploratory
exploratory endpoint
Exploratory endpoints
female
Formulation
GAD-7
Generalized
Generalized Anxiety Disorder
Genetic variation
HCQ
Health care
HLA haplotypes
hospital
Hospitalization
hospitalizations
Hydroxychloroquine
Hypothesis
identify
include
Inclusion
independent
individual
Infection
information
intensive care unit
lactation
masking
mental health
Meta-analysis
Mortality
Nasopharyngeal swab
nasopharyngeal swab sample
Nasopharyngeal swab samples
number
number of deaths
objective
onset of symptom
open care
outcome
Outpatient
outpatients
parallel-group
participant
Patient
patient data
PCR test
PCR testing
PCR-confirmed
Placebo
placebo-controlled
post-hoc
predict
Pregnancy
presenting
primary care
primary endpoint
protocol
public health
public health care
randomised
randomised controlled trial
randomization list
Randomized
Randomly
receive
recruitment
reduce
Registered
Regulation
repeated
reported
respiratory
respiratory distress
respiratory rate
response
risk
room air
SAEs
Sample size
SARS-CoV-2
SARS-CoV-2 PCR test
SARS-CoV-2 viral shedding
Satakunta
secondary endpoint
Secondary endpoints
Secondary objectives
serious AE
serum
Seven
severe pneumonia
severity
specific treatment
status
study participant
Study participants
study population
Study protocol
subgroup analysis
subject
supplementary material
Suspected
Symptom
Symptoms
technology
test result
therapeutic potential
Tolerability
treated
Treatment
treatment allocation
treatment arm
Trial
Trial registration
twice a day
type 1 or type 2
Uppsala
variable
Viral
was performed
website
Well-being
[DOI] 10.1186/s13063-020-04989-6 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04989-6 PMC 바로가기 [Article Type] Letter
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)
Kampo 의약품을 사용한 COVID-19 예방에 대한 다기관, 무작위 대조 시험(RCT) 연구 프로토콜의 구조화된 요약(예방 연구에 의한 전염병에 대한 일본의 통합 관리: IMJEDI P1 연구)
Letter
[키워드] 1:1
administration
age
allergic
Analysis
appearance
Arm
ARMS
assumed
Asymptomatic
balancing
Blinding
body temperature
calculated
capture
cardiovascular disease
Chain Reaction
clinical
clinical trials
cloud
condition
Control
control group
cough
COVID-19
diabetes
disappearance
dissemination
doctor
dosage
dropout rate
drug
edema
effective
element
Endpoint
exclusion criteria
failure
Fever
Final
final analysis
final analysis)
Frequency
group
hands
healthy
history
hospital
Hospitalization
hypertension
hypokalaemia
Hypothesis
ICU
Immunosuppressant
immunosuppressants
incidence of COVID-19
incidence rate
incidence rates
include
inclusion criteria
Infection
infection rate
Inflammation
interim analysis
interstitial pneumonia
intervention group
investigator
Japan
Japanese
Kampo
Kampo medicines
liver dysfunction
lung
malaise
management
mechanical ventilation
Medicine
number
numbness
objective
observation period
oral administration
oral administration)
outcome
package
parallel-group
participant
Patient
PCR
PCR positive
per day
Period
pharmaceutical
Placebo
placebo group
Placebo tablets
positive result
power
power of 80%
pregnant
Prevent
Prophylactic
prophylactic study
protocol
randomised
Randomized
Randomized controlled trial
RCT
receive
recruited
Registered
Registration
registry
required
Research
respiratory
respiratory diseases
respiratory inflammation
risk factor
Risk factors
Safety
Sample size
SARS-CoV-2 RNA
secondary
Secondary outcomes
Shock
Shortness of breath
significantly
skin rash
sputum
study drug
study period
Study protocol
supplementary material
Symptom
Symptoms
symptoms of COVID-19
Tablet
Taking
Taste
the placebo group
Trial
Trial registration
Two-arm
university
upper respiratory
verification
Viral
viral infection
Vital
website
[DOI] 10.1186/s13063-020-04939-2 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04939-2 PMC 바로가기 [Article Type] Letter
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery
코로나바이러스 질병 2019 환자의 시험에 대한 핵심 결과 측정: 호흡 부전, 다기관 부전, 숨가쁨 및 회복
Clinical Investigations
[키워드] 5-point Likert scale
absence
activities
activity
applicability
assessment
capture
Care
clinical
clinical care
clinical trial
Consensus
Consistency
content
content validity
core
coronavirus
coronavirus disease
Coronavirus disease 2019
coronavirus disease 2019)
country
Critical care
de novo
Decision-making
defined
Digital
Digital Content
domain
Evidence
extreme
failure
feasible
fluctuation
Health
Health Organization
Inclusion
Infection
International
measure
Measures
Medical Research Council
Mortality
multiple organ failure
Organ failure
outcome
outcome measure
outcome measures
participant
Patient
patients
Pragmatic
professionals
recall
respiratory
Respiratory failure
Respiratory Support
scale
Sepsis
Sequential Organ Failure Assessment
severity
Shortness of breath
Symptoms
text
Trial
Validity
World Health Organization
[DOI] 10.1097/CCM.0000000000004817 PMC 바로가기 [Article Type] Clinical Investigations
[DOI] 10.1097/CCM.0000000000004817 PMC 바로가기 [Article Type] Clinical Investigations